Skip to article
Astra

Pulmonary Vascular Medicine

Pulmonary Embolism Risk Stratification

Risk stratification in acute pulmonary embolism separates patients requiring immediate reperfusion from those appropriate for anticoagulation, monitored escalation, or outpatient care by integrating hemodynamics, clinical severity scores, right-ventricular assessment, and cardiac biomarkers.

Clinical question: How should physicians classify acute pulmonary embolism severity to determine reperfusion, monitoring intensity, and outpatient eligibility?

First decision

Classify hemodynamic risk before calculating prognostic scores

Disposition and reperfusion decisions begin with circulatory status.

Classify suspected or confirmed PE as high risk when there is hemodynamic instability. This phenotype is associated with substantially greater short-term mortality than normotensive PE and requires immediate resuscitative management and consideration of reperfusion rather than waiting for formal PESI, sPESI, biomarker, or RV-imaging results.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationOxford AcademicEndovascular management of intermediate-risk pulmonary embolism

For PE presenting with shock or cardiac arrest, emergent systemic thrombolysis or embolectomy is reasonable.AHA JournalsInterventional Treatment of Pulmonary Embolism | Circulation Catheter-based therapies are designed to rapidly reduce pulmonary artery pressure, RV strain, and pulmonary vascular resistance and are potential escalation options when advanced intervention is being considered.AHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...

In hemodynamically stable PE, do not equate normal blood pressure with low risk. Continue risk assessment with a clinical severity tool, RV assessment, and cardiac biomarkers to separate low-risk patients from intermediate-risk patients who require inpatient observation and possible rescue therapy if they worsen.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism

Hemodynamic status determines the first PE risk-stratification branch.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationOxford AcademicEndovascular management of intermediate-risk pulmonary embolism
PresentationRisk implicationImmediate management consequence
Shock or cardiac arrestHigh-risk PE; associated with high short-term mortality.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationOxford AcademicEndovascular management of intermediate-risk pulmonary embolismConsider emergent systemic thrombolysis or embolectomy; evaluate catheter-based options within an advanced PE pathway.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...
Normotensive without shockRequires further clinical, imaging, and biomarker stratification; normal blood pressure alone does not establish low risk.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsUse clinical severity assessment plus RV and biomarker evaluation to guide monitoring and disposition.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports

Clinical prognosis

Use PESI or sPESI to identify baseline mortality risk and disposition candidates

Clinical scores organize comorbidity and physiologic risk but do not replace hemodynamic assessment.

Use the Pulmonary Embolism Severity Index (PESI) or simplified PESI (sPESI) in a normotensive patient after PE is confirmed or strongly established. These tools are incorporated into contemporary PE risk assessment and are also used to support selection of potential outpatient candidates.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsOxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...

A high PESI category should not be interpreted as a direct indication for thrombolysis. Rather, it identifies a patient in whom inpatient management, assessment for RV dysfunction, and biomarker evaluation are more consequential because clinical risk is not low.BMJCombinations of prognostic tools for identification of high-risk ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports

Conversely, a favorable sPESI or Hestia assessment supports consideration of home treatment only after confirming hemodynamic stability and excluding practical or clinical barriers to ambulatory care. Outpatient selection remains a clinical disposition decision, not a score-only decision.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...WileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...

Clinical scores serve different decisions in normotensive acute PE.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsOxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...
Tool or findingBest useWhat it should not determine alone
PESIClinical prognostic classification; higher classes identify a population in which combined prognostic assessment is useful.BMJCombinations of prognostic tools for identification of high-risk ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsNeed for thrombolysis or catheter intervention.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports
sPESIStructured identification of lower-risk patients being considered for ambulatory management.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...Automatic home discharge without hemodynamic and clinical suitability assessment.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...
Hestia ruleOutpatient eligibility screening in clinically stable PE.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...Replacement for physician assessment of treatment feasibility and follow-up.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...

Intermediate-risk assessment

Integrate RV dysfunction and biomarkers rather than acting on either alone

RV injury identifies a higher-risk normotensive phenotype but requires clinical context.

Evaluate RV dysfunction in normotensive PE when risk stratification will affect level of care or consideration of escalation. RV dysfunction has prognostic value and is omitted from some widely used risk models, supporting its use as a complementary—not competing—assessment to PESI or sPESI.BMJbased prognostic factors associated with mortality in pulmonary ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports

CT pulmonary angiography and echocardiography provide RV-focused imaging information, while troponin and natriuretic peptide testing may identify myocardial injury or strain. Current evidence does not support using any individual laboratory marker or imaging sign as sufficient justification for advanced therapy.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports

A clinically higher-risk patient with both RV dysfunction and biomarker abnormality merits close inpatient monitoring because decompensation may require rescue reperfusion. In contrast, the absence of these adverse features helps support a low-risk classification when the clinical score and disposition assessment are also favorable.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism

Interpretation of adverse findings in normotensive PE requires a multimodal framework.BMJbased prognostic factors associated with mortality in pulmonary ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports
FindingPrognostic interpretationNext action
Elevated PESI or unfavorable sPESIHigher baseline clinical risk; may identify patients requiring additional prognostic assessment.BMJCombinations of prognostic tools for identification of high-risk ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAssess RV function and cardiac biomarkers; plan inpatient care rather than assuming low risk.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports
RV dysfunction on CTPA or echocardiographyAdverse prognostic marker that complements clinical risk scores.BMJbased prognostic factors associated with mortality in pulmonary ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsIntegrate with hemodynamics, clinical severity, and biomarkers; increase monitoring when the overall profile is unfavorable.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism
Elevated cardiac biomarkerSuggests myocardial injury or strain but is not independently sufficient to justify advanced therapy.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsUse with RV and clinical findings to determine observation intensity and readiness for rescue escalation.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism
Single abnormal RV or biomarker result in a stable patientDoes not independently establish a need for advanced intervention.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsContinue anticoagulation-focused management and reassess the integrated risk profile.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism

Why combined assessment matters

Clinical prediction scales, RV dysfunction, and biomarkers measure different dimensions of PE severity. Combining them improves the practical identification of patients whose initial normotension may not represent a durable low-risk state, while avoiding escalation based only on a single abnormal test.BMJbased prognostic factors associated with mortality in pulmonary ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports

Therapeutic consequence

Match reperfusion and monitoring intensity to the evolving risk category

Anticoagulation is foundational; reperfusion is reserved for selected high-risk or deteriorating patients.

Anticoagulation is the cornerstone of PE treatment across risk groups.AHA JournalsInterventional Therapies for Acute Pulmonary Embolism In high-risk PE with shock or arrest, the immediate decision is whether systemic thrombolysis, surgical embolectomy, or catheter-based intervention offers the fastest appropriate reperfusion strategy.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...

For intermediate-risk PE, initial management generally centers on anticoagulation and monitored observation rather than routine primary reperfusion. The key operational decision is to define deterioration triggers in advance: recurrent hypotension, shock, arrest, or worsening clinical evidence of RV failure should prompt immediate reassessment for rescue systemic, catheter-based, or surgical reperfusion.AHA JournalsInterventional Therapies for Acute Pulmonary EmbolismAHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...

Catheter-based intervention is most relevant when rapid reduction in RV strain and pulmonary vascular obstruction is needed in an advanced-therapy pathway, particularly when systemic thrombolysis is unsuitable or when clinical status worsens despite initial treatment. Procedural selection should incorporate local expertise and the urgency of hemodynamic compromise.AHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...

Risk-stratified treatment posture in acute PE.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary EmbolismAHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...
Risk phenotypeInitial treatment postureEscalation trigger
High-risk PE with shock or arrestImmediate anticoagulation-centered management plus consideration of emergent systemic thrombolysis or embolectomy.AHA JournalsInterventional Therapies for Acute Pulmonary EmbolismAHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationHemodynamic collapse is itself the trigger for immediate reperfusion assessment.AHA JournalsInterventional Treatment of Pulmonary Embolism | Circulation
Normotensive PE with adverse clinical, RV, or biomarker profileAnticoagulation with close monitoring; use combined findings for risk assignment.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary EmbolismNew hypotension, shock, arrest, or worsening clinical RV failure should prompt rescue reperfusion evaluation.AHA JournalsInterventional Therapies for Acute Pulmonary EmbolismAHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary Embolism ...
Low-risk stable PEAnticoagulation and evaluate for outpatient management using structured low-risk assessment.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...WileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...Failure of outpatient eligibility criteria or new clinical instability warrants inpatient management and reassessment.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...

Disposition

Select outpatient PE treatment only after a structured low-risk screen

Home treatment is a disposition decision after medical stability is established.

Consider outpatient PE management in nonpregnant patients who are hemodynamically stable and meet a validated low-risk assessment such as sPESI or Hestia criteria.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...WileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ... The selection process should occur after excluding the high-risk and monitored intermediate-risk phenotypes, not immediately after a positive diagnostic scan.

A patient with unfavorable clinical severity assessment, RV dysfunction, biomarker elevation, or uncertainty about imminent deterioration should generally remain under observation while the integrated risk profile is clarified.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsAHA JournalsInterventional Therapies for Acute Pulmonary Embolism Favor inpatient care when the need for rescue intervention cannot be safely excluded.

For patients discharged after a low-risk assessment, the critical operational requirement is reliable treatment implementation and follow-up sufficient to detect early clinical worsening. If treatment access, follow-up, or reassessment capacity is inadequate, structured scores should not override disposition safety concerns.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...

Disposition framework for hemodynamically stable PE.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsOxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...WileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...
Disposition considerationSupports outpatient treatmentSupports inpatient monitoring
HemodynamicsStable circulation.Oxford AcademicSafety of treating acute pulmonary embolism at homeOxford AcademicExpanding outpatient management of low-risk pulmonary embolism ...Shock, arrest, or evolving instability.AHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationOxford AcademicEndovascular management of intermediate-risk pulmonary embolism
Structured clinical assessmentLow-risk sPESI or Hestia assessment.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...Unfavorable clinical severity profile.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports
RV and biomarker profileNo adverse profile requiring monitored reassessment in the overall clinical context.NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific ReportsRV dysfunction and/or biomarker abnormalities contributing to an intermediate-risk profile.BMJbased prognostic factors associated with mortality in pulmonary ...NatureMultimodal fusion models for pulmonary embolism mortality prediction | Scientific Reports
Clinical feasibilityAppropriate ambulatory treatment and follow-up can be implemented.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...Uncertain treatment implementation, follow-up, or capacity for prompt reassessment.Oxford AcademicSafety of treating acute pulmonary embolism at homeWileyOutcomes of Acute PE Treated With DOACs in the Veterans Affairs ...

References

  1. Combinations of prognostic tools for identification of high-risk ...thorax.bmj.com · thorax.bmj.com
  2. based prognostic factors associated with mortality in pulmonary ...thorax.bmj.com · thorax.bmj.com
  3. Acute Pulmonary Embolism: A Review | Emergency Medicine | JAMAjamanetwork.com · jamanetwork.com
  4. High-Sensitivity vs Conventional Troponin Cutoffs for Risk ...jamanetwork.com · jamanetwork.com
  5. Management dilemmas in acute pulmonary embolismthorax.bmj.com · thorax.bmj.com
  6. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism | Thoraxthorax.bmj.com · thorax.bmj.com
  7. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM ... - JACCwww.jacc.org · www.jacc.org
  8. Pulmonary embolism | Nature Reviews Disease Primerswww.nature.com · www.nature.com
  9. Current use of D-dimer for the exclusion of venous thrombosis in hospitalized patients | Scientific Reportswww.nature.com · www.nature.com
  10. Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolismwww.acpjournals.org · www.acpjournals.org
  11. Machine learning improves prediction of pulmonary thromboembolism and reduces unnecessary computed tomography scans in the emergency department | Scientific Reportswww.nature.com · www.nature.com
  12. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Forcewww.jacc.org · www.jacc.org
  13. Evaluation of Patients With Suspected Acute Pulmonary Embolismwww.acpjournals.org · www.acpjournals.org
  14. Multimodal fusion models for pulmonary embolism mortality prediction | Scientific Reportswww.nature.com · www.nature.com
  15. Interventional Therapies for Acute Pulmonary Embolismwww.ahajournals.org · www.ahajournals.org
  16. Interventional Treatment of Pulmonary Embolism | Circulationwww.ahajournals.org · www.ahajournals.org
  17. Management of Massive and Submassive Pulmonary Embolism ...www.ahajournals.org · www.ahajournals.org
  18. Management of Deep Vein Thrombosis and Pulmonary Embolismwww.ahajournals.org · www.ahajournals.org
  19. Safety of treating acute pulmonary embolism at homeacademic.oup.com · academic.oup.com
  20. Expanding outpatient management of low-risk pulmonary embolism ...academic.oup.com · academic.oup.com
  21. Outcomes of Acute PE Treated With DOACs in the Veterans Affairs ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  22. Choosing the Right Tool: Comparing Risk Stratification Models in ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  23. Endovascular management of intermediate-risk pulmonary embolismacademic.oup.com · academic.oup.com
  24. Revised Paradigm for Acute Pulmonary Embolism Prognostication ...academic.oup.com · academic.oup.com